SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%
Eli Lilly and Company (LLY) Doesn’t Excite Hedge Funds
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain
Insider Monkey · 1天前
Drugs standards group nixes plan to kick pharma's crab blood habit
Horseshoe crabs' icy-blue blood is set to remain the drug industry's standard for safety tests after a powerful U.S. group ditched a plan to put on an equal footing a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups. The crabs' cop
Reuters · 1天前
Lilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA® (ramucirumab injection, 10 mg/mL solution), in combination with erlotinib, for the first-line treatment of people with metastatic non-small
PR Newswire · 1天前
FDA Okays Lilly's Alzheimer's Disease Diagnostic Agent Tauvid
With the US regulatory agency's nod, Eli Lilly's (LLY) Tauvid became the first and the only approved radioactive diagnostic agent to image tau NFTs in the brain for effectively evaluating AD patients.
Zacks · 2天前
Lilly Cleared by FDA to Market Alzheimer's Detection Drug
TheStreet.com · 2天前
Pharma Stock Roundup: MRK, RHHBY Give Coronavirus Updates,SNY to Sell Stake in REGN
Zacks · 2天前
Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates
Zacks · 2天前
European advisory group backs new indications of five meds
Seeking Alpha - Article · 2天前
Lilly gets FDA approval for Alzheimer's diagnostic agent
Shares of Eli Lilly & Co. gained 0.8% in premarket trading on Friday, the day after the Food and Drug Administration (FDA) approved Tauvid, a drug used to help diagnose tau neurofibrillary tangles in people suspected of having Alzheimer's disease. The diagnos
MarketWatch · 2天前
Stocks making the biggest moves premarket: Costco, Salesforce, Eli Lilly, Tyson Foods & more
These are the stocks posting the largest moves before the bell.
CNBC.com · 2天前
Wall Street Breakfast: U.S.-China Tension Ratchets Up
Seeking Alpha - Article · 2天前
All eyes on ASCO
Seeking Alpha - Article · 2天前
FDA approves Eli Lilly Alzheimer's diagnosis drug
Seeking Alpha - Article · 2天前
Eli Lilly Earns Landmark Approval for Alzheimer's Disease Imaging Agent
It's not a treatment for this memory-robbing dementia, but it could help Lilly and its peers find one.
Motley Fool · 2天前
Lilly Receives U.S. FDA Approval of TAUVID™ (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer's Disease
TAUVID™, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairm
PR Newswire · 2天前
U.S. FDA approves Eli Lilly's diagnostic agent for Alzheimer's disease
Reuters · 2天前
Thursday Morning Market Highlights
GuruFocus.com · 2天前
3 Investing Facts About Required Minimum Distributions You Need to Know - May 28, 2020
Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.
Zacks · 3天前
Why Is This Fast-Growing Biotech So Undervalued?
MotleyFool.com · 3天前
Sanofi's Dupixent Gets FDA Approval for Eczema in Children
Zacks · 4天前